GC Aesthetics Launches Luna XT and PERLE in Hainan, China

GC Aesthetics, a designer, manufacturer, and distributor of breast implants and medical devices for the global aesthetics industry has entered into the Chinese market with two of its key products: Luna XT and PERLE. This marks a significant milestone in the company’s expansion strategy, aimed at providing innovative aesthetic solutions for patients and surgeons worldwide.

 

The evolving beauty standards and the cultural emphasis on personal appearance in China have opened an opportunity for GC Aesthetics to enter the market.

 

Carlos Reis Pinto, CEO at GC Aesthetics, said: “Our expansion into China is a testament to our dedication to meeting global demand with high-quality products. We are thrilled to partner with Gaoshi Group and look forward to a prosperous future in this dynamic market, offering patients safe, reliable, and innovative products”

 

The new Luna XT Anatomical Breast Implant provides industry-leading support for women undergoing immediate and delayed breast reconstruction surgery. Its unique, microtextured surface, highly cohesive silicone gel, and high-performance shell are a state-of-the-art option for women who wish to undergo breast procedures. 

 

Luna XT is available in a variety of projections, heights, and volumes which makes it an all-rounder to suit different patients and their needs, it is also the first breast implant on the market under the latest Medical Device Regulation (MDR).

 

PERLE features a BioQ-Surface, Emunomic Breast Tissue Dynamic Gel, and an advanced RRE patch to produce a smooth, opaque breast implant. The product was launched in Europe in 2021 and continues to be introduced in key markets including China.  PERLE is highly respected by surgeons all over Europe and is positioned to be the preferred type of breast implant surface.